Article Information
History
- March 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yanan Hou1,2,*,
- Huajie Dai1,2,*,
- Na Chen1,2,*,
- Zhiyun Zhao1,2,*,
- Qi Wang1,2,
- Tianzhichao Hou1,2,
- Jie Zheng1,2,
- Tiange Wang1,2,
- Mian Li1,2,
- Hong Lin1,2,
- Shuangyuan Wang1,2,
- Ruizhi Zheng1,2,
- Jieli Lu1,2,
- Yu Xu1,2,
- Yuhong Chen1,2,
- Ruixin Liu1,2,
- Guang Ning1,2,
- Weiqing Wang1,2,
- Yufang Bi1,2,a,†,
- Jiqiu Wang1,2,a,† and
- Min Xu1,2,a,†
- 1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 2Shanghai National Clinical Research Center for metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- ↵aAddress of Correspondence: Min Xu, MD&PhD, Professor of medicine, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. E-mail: della.xumin{at}shsmu.edu.cn; Jiqiu Wang, MD&PhD, Professor of medicine, Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 200025. Email: wangjq{at}shsmu.edu.cn; Yufang Bi, MD&PhD, Professor of medicine, Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Email: byf10784{at}rjh.com.cn.
↵* These authors contributed equally to the work
Posted March 02, 2023.
A whole blood-based transcriptional risk score for nonobese type 2 diabetes predicts dynamic changes in glucose metabolic traits
